Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 2Phase 3 1Phase 1/2 1

Status

Completed 3Not yet recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 78INDUSTRY 7NETWORK 1

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 2Dermatologic 2Gynecologic 1Genitourinary 1Breast 1

Conditions

Melanoma 2Carcinoma, Hepatocellular 2Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Squamous Intraepithelial Lesions 1Prostatic Neoplasms 1Liver Diseases 1

Interventions

pembrolizumab 1019Carboplatin 959Paclitaxel 932Gemcitabine 793Cisplatin 748Docetaxel 682Bevacizumab 610Pemetrexed 502Nivolumab 486Cyclophosphamide 466Capecitabine 461Fluorouracil 417Dexamethasone 402Rituximab 372Oxaliplatin 347Injections 342atezolizumab 297Trastuzumab 297Leucovorin 286Cetuximab 282Irinotecan 266130-nm albumin-bound paclitaxel 252Prednisone 244Doxorubicin 240Ipilimumab 226Lenalidomide 220Fulvestrant 217fludarabine 214durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Electroporation × Clear all
NCT07191548 2025-10-10

LIVERMET-IRE

Angiodynamics, Inc.

Phase NA Not yet recruiting
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT07192731 2025-10-10

LIVERHCC-IRE

Angiodynamics, Inc.

Phase NA Not yet recruiting
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04972097 2025-02-12

PRESERVE

Angiodynamics, Inc.

Phase NA Completed
121 enrolled
Genitourinary

Prostatic Neoplasms

NCT03185013 2023-07-27

REVEAL 1

Inovio Pharmaceuticals

Phase 3 Completed
201 enrolled 23 charts
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

NCT02531425 2023-05-15

TNBC

OncoSec Medical Incorporated

Phase 1 Completed
10 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01045915 2015-09-11

AMEP

Valerio Therapeutics

Phase 1 Terminated
5 enrolled
Dermatologic

Melanoma

NCT01764009 2015-09-11

AIMM

Valerio Therapeutics

Phase 1/2 Withdrawn
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡